Autism Spectrum Disorder Diagnostics Market Report 2026

The autism spectrum disorder diagnostics market size has grown strongly in recent years. It will grow from $28.87 billion in 2025 to $30.37 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to increased awareness of autism spectrum disorders, expansion of pediatric developmental screening programs, availability of trained diagnostic professionals, growing use of behavioral assessment frameworks, improved access to diagnostic services.

The autism spectrum disorder diagnostics market size is expected to see steady growth in the next few years. It will grow to $36.76 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to rising demand for early intervention services, increasing use of ai-assisted diagnostic tools, expansion of tele-diagnostics platforms, growing investment in neurodevelopmental research, improved standardization of diagnostic criteria. Major trends in the forecast period include increasing adoption of digital screening tools, growing use of standardized behavioral assessment scales, expansion of early childhood diagnostic programs, rising integration of multidisciplinary diagnostic approaches, enhanced focus on early and accurate detection.

The expansion of specialized diagnostic centers is expected to drive the growth of the autism spectrum disorders diagnostic market in the coming years. An autism-focused diagnostic center is a facility staffed with healthcare professionals, psychologists, and specialists who perform comprehensive evaluations and assessments to diagnose autism spectrum disorder. The increase in specialized diagnostic centers is driven by advancements in diagnostics, demand for comprehensive care, professional training, research, and the recognition of autism as a public health priority. These centers play a crucial role in improving diagnostic accuracy, enabling early intervention, and enhancing outcomes for individuals with ASD by offering specialized expertise, advanced diagnostic tools, thorough assessments, personalized treatment plans, family support, and opportunities for research collaboration. For example, in July 2025, according to NHS England, the U.K.-based government agency providing health services, the national Community Diagnostic Centre (CDC) Programme approved 170 CDC sites across England. As of August 2024, 165 sites were operational in various settings; of these, 135 were operating from permanent CDC buildings, while the remainder operated from temporary facilities until their permanent CDC buildings were completed. Consequently, the growth of specialized diagnostic centers is contributing to the expansion of the autism spectrum disorders diagnostic market.

Leading companies in the autism spectrum disorder diagnostics market are developing advanced solutions, such as devices that use Dynamic Quantification of Social-Visual Engagement (DQSVE), to gain a competitive advantage. This technology captures and analyzes a child's moment-by-moment gaze behavior at a rate of 120 times per second. For example, in September 2023, Marcus Autism Center, a US-based nonprofit healthcare and research organization, introduced the EarliPoint™ Evaluation, an FDA-authorized device designed for the early diagnosis of autism spectrum disorder (ASD) in children aged 16 to 30 months. This innovative tool employs eye-tracking technology to evaluate children's social interactions, significantly reducing the time required for diagnosis from several hours to approximately 12 minutes.

In March 2024, Fletch Equity LLC, a US-based private equity firm, acquired Autism Spectrum Interventions (ASI) for an undisclosed amount. Through this acquisition, Fletch Equity aims to support ASI's growth and expansion across California and potentially into neighboring states. Autism Spectrum Interventions (ASI) is a US-based provider of applied behavior analysis (ABA) therapy, specializing in services for children with autism spectrum disorder (ASD).

Major companies operating in the autism spectrum disorder diagnostics market are Quest Diagnostics, Laboratory Corporation of America LabCorp, ARUP Laboratories, Invitae, Natera, Fulgent Genetics, Myriad Genetics, Sema4, PreventionGenetics, Color Genomics, Cognoa, EarliTec Diagnostics, Eurofins Scientific, Sonic Healthcare, Cerba HealthCare, Baylor Genetics, Mayo Clinic Laboratories, Bionano Genomics, Genomind, Blueprint Genetics.

Asia-Pacific was the largest region in the autism spectrum disorder diagnostics market in 2025. The regions covered in the autism spectrum disorder diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the autism spectrum disorder diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the autism spectrum disorder diagnostics market by increasing costs of imported diagnostic instruments, digital assessment platforms, specialized testing software, and medical devices used in neurodevelopmental evaluations. Diagnostic centers and hospitals in North America and Europe are most affected due to dependence on imported equipment, while Asia-Pacific faces higher costs for expanding diagnostic infrastructure. These tariffs are increasing diagnostic service costs and slowing technology upgrades. At the same time, they are encouraging local development of diagnostic tools, regional software innovation, and domestic production of assessment equipment.

The autism spectrum disorder diagnostics market research report is one of a series of new reports that provides autism spectrum disorder diagnostics market statistics, including autism spectrum disorder diagnostics industry global market size, regional shares, competitors with a autism spectrum disorder diagnostics market share, detailed autism spectrum disorder diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the autism spectrum disorder diagnostics industry. This autism spectrum disorder diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Autism spectrum disorder (ASD) diagnostics encompass the various methods and tools used to detect and evaluate individuals suspected of having autism spectrum disorder. The purpose of ASD diagnostics is to accurately determine the presence and intensity of ASD symptoms, enable early intervention, and inform personalized treatment plans. These evaluations are performed by healthcare professionals who specialize in neurodevelopmental disorders and are essential for delivering timely support and services to individuals on the autism spectrum and their families.

The primary types in the autism spectrum disorder diagnostics market include autistic disorder, Asperger syndrome, pervasive developmental disorder (PDD), and others. Autistic disorder is a neurodevelopmental condition marked by difficulties in social interaction, communication, and repetitive behaviors. The range of services comprises behavioral approaches, early intervention, medication, and others, with distribution channels including hospital pharmacies, drug stores and retail pharmacies, and online pharmacies.

The autism spectrum disorder (ASD) diagnostics market consists of revenues earned by entities by providing services such as behavioral assessments, genetic testing, speech and language evaluations, and psychological assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. The autism spectrum disorder (ASD) diagnostics market also includes sales of diagnostic tests and kits, neuroimaging equipment, and behavioral assessment tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.